Kennedy Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$120K Sell
2022
Q3
$217K Sell
2022
Q2
$350K Sell
2022
Q1
$336K Buy